New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement

IDNAvsIBBQETF Comparison

ETF 1
IDNA

iShares Genomics Immunology and Healthcare ETF

This fund is part of
BioTech & Genomics
+0.3%
VS
ETF 2
IBBQ

Invesco Nasdaq Biotechnology ETF

This fund is part of
US Health Care
-1.03%

iShares Genomics Immunology and Healthcare ETF (IDNA) belongs to the BioTech & Genomics segment. Invesco Nasdaq Biotechnology ETF (IBBQ) is part of the US Health Care segment. IDNA's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, IBBQ's top sector exposures are Healthcare and Non-Energy Materials. IDNA is more expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.19% for IBBQ. IDNA is up 56.97% year-to-date (YTD) with +$107M in YTD flows. IBBQ performs worse with 22.86% YTD performance, and +$38M in YTD flows. Run a side-by-side ETF comparison of IDNA and IBBQ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IDNA vs IBBQ performance and flow charts

Performance

-4.0-2.00.02.04.0%Sep 23Sep 30Oct 7Oct 14Oct 21

Cumulative Flows

0 M10 M20 M30 M40 MSep 23Sep 30Oct 7Oct 14Oct 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/23/2026
1M3MYTD1Y3Y5Y
Perf.
IDNA
IBBQ
+0.71%-0.34%
+26.25%+7.21%
+56.97%+22.86%
+68.01%+36.10%
+137.40%+90.27%
-14.00%+44.83%
Flows
IDNA
IBBQ
+$44M+$14M
+$78M+$35M
+$107M+$38M
+$106M+$56M
+$84M+$74M
+$64M+$52M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IDNA
IBBQ
+40.06%+25.52%
+29.07%+22.48%
+26.03%+21.25%
+28.83%+22.22%
Max drawdown
IDNA
IBBQ
-8.56%-8.58%
-10.60%-8.58%
-29.33%-23.78%
-65.57%-34.86%
Max drawdown duration
IDNA
IBBQ
27d65d
46d65d
347d375d
1815d1429d
Trading data

Create an account to view trading data

Join for free
IDNA
IBBQ
Last sale
10/23/2026 at 1:30 PM
$40.91
$34.52
Previous close
10/22/2026
$41.04
$34.92
Consolidated volume
10/22/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IDNA
IBBQ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
IDNA
IBBQ
Last price
$40.91
$34.52
1D performance
-0.32%
-1.15%
AuM$321.28 M$115.07 M
E/R0.47%0.19%
Characteristics
IDNA
IBBQ
Management strategyPassivePassive
ProvideriSharesInvesco
BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma IndexNASDAQ Biotechnology Index
N° of holdings48249
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 11, 2019June 9, 2021
ESGNoNo
Advertisement
Exposure

Countries

IDNA
USA
63.78%
Germany
7.53%
Other
28.69%
IBBQ
USA
88.22%
Other
11.78%

Sectors

IDNA
Healthcare
99.75%
Other
0.25%
IBBQ
Healthcare
99.99%
Other
0.01%
Advertisement

Diversification

IDNA

Total weight of top 15 holdings out of 15

61.2%
IBBQ

Total weight of top 15 holdings out of 15

52.06%

Top 15 holdings

Data as of August 31, 2026
IDNA
Moderna, Inc.
8.85%
Twist Bioscience Corp.
6.01%
Revolution Medicines, Inc.
4.12%
Bayer AG
4.08%
Genmab A/S
4.00%
Regeneron Pharmaceuticals, Inc.
3.76%
Merck & Co., Inc.
3.66%
Vertex Pharmaceuticals, Inc.
3.65%
Incyte Corp.
3.60%
Takeda Pharmaceutical Co., Ltd.
3.51%
BioNTech SE
3.45%
Roche Holding AG
3.17%
IDEAYA Biosciences, Inc.
3.13%
Ipsen SA
3.11%
Exelixis, Inc.
3.10%
IBBQ
Amgen, Inc.
8.60%
Vertex Pharmaceuticals, Inc.
8.10%
Gilead Sciences, Inc.
7.34%
Regeneron Pharmaceuticals, Inc.
5.26%
Moderna, Inc.
3.58%
Revolution Medicines, Inc.
2.97%
Illumina, Inc.
2.18%
Biogen, Inc.
2.07%
Alnylam Pharmaceuticals, Inc.
2.00%
argenx SE
1.84%
Royalty Pharma Plc
1.73%
Roivant Sciences Ltd.
1.71%
Insmed, Inc.
1.66%
Incyte Corp.
1.61%
United Therapeutics Corp.
1.42%
Frequently asked questions about IDNA and IBBQ

How have the IDNA and IBBQ ETFs performed in 2026?

As of October 23, 2026, IDNA is up 56.97% year-to-date (YTD), while IBBQ has returned 22.86%. That puts IDNA better performer ahead so far this year.

Which ETF is attracting more investor money: IDNA or IBBQ?

Year-to-date, the IDNA ETF saw +$107M in flows, compared to +$38M for IBBQ.

Which ETF is more volatile: IDNA or IBBQ?

Over the past year, IDNA had a volatility of 29.07%, while IBBQ experienced 22.48%.

Which ETF is bigger: IDNA or IBBQ?

As of October 23, 2026, IDNA holds $321.28 M in assets under management (AUM), while IBBQ manages $115.07 M.

What sectors do the IDNA and IBBQ ETFs invest in?

IDNA leans toward sectors like Healthcare. Meanwhile, IBBQ focuses on Healthcare.

What are the top holdings of the IDNA ETF and IBBQ ETF?

IDNA top holdings include Moderna, Inc., Twist Bioscience Corp. and Revolution Medicines, Inc.. IBBQ holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc..

Which ETF is more diversified: IDNA or IBBQ?

IDNA holds 48 securities with 61.2% of its assets in the top 15. IBBQ has 249 securities and a top 15 weight of 52.06%.

Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026